Stifel analyst Alex Thompson CFA maintains $RAPT Therapeutics (RAPT.US)$ with a hold rating, and maintains the target price at $2.
According to TipRanks data, the analyst has a success rate of 61.2% and a total average return of 17.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $RAPT Therapeutics (RAPT.US)$'s main analysts recently are as follows:
Rapt Therapeutics' recent discontinuation of the zelnecirnon program came after FDA feedback indicated challenges in disproving drug-induced liver failure. The lack of data disclosure and the uncertainty that surrounds the development of next-generation compounds, which may require additional capital, suggests Rapt now needs to demonstrate more to gain confidence.
The FDA's request for definitive evidence concerning liver SAEs was more conservative than expert expectations. Despite this, there is an observed efficacy signal from Phase 2b, which is promising for the next-generation compound. Further data is anticipated to evaluate the potential.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
